Skip to search formSkip to main contentSkip to account menu

risedronate sodium

Known as: 2-(3-pyridinyl)-1-hydroxyethylidenebisphosphonate, Risedronate Sodium [Chemical/Ingredient], Monosodium (1-hydroxy-2-(3-pyridinyl)ethylidene)bisphosphonate 
The sodium salt of risedronic acid, a synthetic pyridinyl bisphosphonate. Risedronic acid binds to hydroxyapatite crystals in bone and inhibits… 
National Institutes of Health

Related topics

Related topics

22 relations

Narrower (2)

ActonelNE 58095

Broader (3)

Bone Density Conservation AgentsCalcium Channel BlockersRisedronate
DiphosphonatesDrug AllergyEsophageal AchalasiaHypocalcemia

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Comparison of the properties of implantable matrices prepared from degradable and non-degradable polymers for bisphosphonate delivery.
2015
2015
Synergistic iontophoretic drug delivery of risedronate sodium in combination with electroporation and chemical penetration enhancer: In‐vitro and in‐vivo evaluation
In the present investigation iontophoretic permeation of risedronate sodium (RS) through optimized gel based formulation was… 
2014
2014
Photonic hydrogel beads for controlled release of risedronate
pH-sensitive photonic composite hydrogel beads composed of sodium alginate and risedronate sodium (SA/RIS) was prepared… 
2013
2013
Identification and management of osteoporosis in older adults
2013
2013
Immunomodulatory Effect of Bisphosphonate Risedronate Sodium on CD163+ Arginase 1+ M2 Macrophages: The Development of a Possible Supportive Therapy for Angiosarcoma
An imbalance of immunosuppressive cells and cytotoxic cells plays an important role in inhibiting the antitumor immune response… 
2011
2011
In vitro disintegration studies of weekly generic and branded risedronate sodium formulations available in Canada
Abstract Objective: The aim of this study was to evaluate the in vitro disintegration of the five newly available Canadian… 
2009
2009
Comparative effects of risedronate, atorvastatin, estrogen and SERMs on bone mass and strength in ovariectomized rats.
2008
2008
Efficacy and safety of risedronate sodium in treatment of postmenopausal osteoporosis
SummaryTo evaluate the efficacy and safety of risedronate sodium in treatment of postmenopausal osteoporosis, one-year randomized… 
2005
2005
Preparation and Evaluation of Floating Risedronate Sodium–Gelucire® 43/01 Formulations
Single and multi-unit floating matrices of risedronate sodium were prepared using Gelucire® 43/01 by melt solidification and melt… 
2005
2005
Efficacy and safety of risedronate sodium in treatment of postmenopausal osteoporosis.
To evaluate the efficacy and safety of risedronate sodium in treatment of postmenopausal osteoporosis, one-year randomized… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)